XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 7.49%487.81B | 7.16%320.62B | 6.34%159.5B | 9.82%609.02B | 10.80%453.82B | 11.02%299.19B | 10.71%149.99B | -0.99%554.55B | -1.52%409.6B | -1.48%269.51B |
Operating income | 7.49%487.81B | 7.16%320.62B | 6.34%159.5B | 9.82%609.02B | 10.80%453.82B | 11.02%299.19B | 10.71%149.99B | -0.99%554.55B | -1.52%409.6B | -1.48%269.51B |
Cost of sales | 3.80%-229.22B | 5.82%-150.85B | 7.55%-75.63B | -0.03%-315.91B | -2.41%-238.27B | -3.63%-160.17B | -4.35%-81.8B | -0.52%-315.81B | -2.14%-232.67B | -4.31%-154.56B |
Operating expenses | 3.80%-229.22B | 5.82%-150.85B | 7.55%-75.63B | -0.03%-315.91B | -2.41%-238.27B | -3.63%-160.17B | -4.35%-81.8B | -0.52%-315.81B | -2.14%-232.67B | -4.31%-154.56B |
Gross profit | 19.97%258.59B | 22.11%169.77B | 23.01%83.87B | 22.77%293.11B | 21.83%215.55B | 20.95%139.02B | 19.46%68.18B | -2.93%238.75B | -5.96%176.92B | -8.33%114.94B |
Selling expenses | -12.32%-26.1B | -8.90%-16.69B | -7.38%-7.54B | -17.04%-34.21B | -0.55%-23.24B | 4.14%-15.33B | 12.91%-7.02B | 28.00%-29.23B | 20.24%-23.11B | 13.77%-15.99B |
Administrative expenses | -6.56%-81.36B | -4.47%-52.3B | -0.68%-24.81B | 2.97%-103.53B | 3.82%-76.35B | 5.37%-50.06B | 7.60%-24.64B | -18.75%-106.7B | -21.25%-79.38B | -27.15%-52.9B |
Special items of operating profit | -58.57%5.49B | 263.44%2.52B | -73.61%1.03B | -96.46%4.7B | -70.19%13.25B | -96.74%692M | -73.73%3.91B | -14.88%132.89B | -34.84%44.45B | -51.22%21.24B |
Operating profit | 21.22%156.62B | 38.97%103.29B | 30.00%52.56B | -32.09%160.07B | 8.69%129.2B | 10.46%74.33B | 8.63%40.43B | -13.22%235.71B | -26.57%118.88B | -38.14%67.28B |
Financing income | --12.09B | 26.89%8.1B | --4.25B | --13.81B | ---- | --6.38B | ---- | ---- | ---- | ---- |
Financing cost | -8.53%-9.47B | 0.05%-5.94B | -6.64%-2.83B | -31.18%-12.27B | -53.23%-8.73B | -58.68%-5.94B | -36.95%-2.65B | -31.46%-9.35B | -8.44%-5.69B | -13.15%-3.74B |
Share of profits of associates | 377.17%15.92B | 699.35%9.9B | 2,632.50%2.19B | 135.96%5.8B | 123.11%3.34B | 111.54%1.24B | 101.27%80M | 1.92%-16.13B | -76.56%-14.44B | -328.06%-10.74B |
Special items of earning before tax | --3.07B | -90.91%2M | --656M | ---6.09B | ---- | --22M | ---- | ---- | ---- | ---- |
Earning before tax | 43.95%178.24B | 51.73%115.35B | 50.08%56.82B | -23.26%161.32B | 25.39%123.82B | 43.99%76.03B | 30.54%37.86B | -15.25%210.23B | -33.49%98.75B | -48.71%52.8B |
Tax | 1.13%-33.24B | -7.64%-24.34B | -23.58%-14.17B | -101.13%-43.28B | -98.44%-33.62B | -129.85%-22.61B | -117.59%-11.47B | -6.24%-21.52B | -3.53%-16.94B | 9.85%-9.84B |
After-tax profit from continuing operations | 60.76%145B | 70.39%91.02B | 61.59%42.65B | -37.44%118.05B | 10.26%90.2B | 24.33%53.42B | 11.21%26.39B | -17.16%188.71B | -38.08%81.81B | -53.32%42.96B |
Earning after tax | 60.76%145B | 70.39%91.02B | 61.59%42.65B | -37.44%118.05B | 10.26%90.2B | 24.33%53.42B | 11.21%26.39B | -17.16%188.71B | -38.08%81.81B | -53.32%42.96B |
Minority profit | 12.16%2.25B | 6.39%1.5B | 37.05%762M | 507.73%2.83B | 1,280.59%2.01B | 51.24%1.41B | 73.75%556M | -84.40%466M | -107.59%-170M | -44.45%931M |
Profit attributable to shareholders | 61.86%142.75B | 72.12%89.52B | 62.12%41.89B | -38.79%115.22B | 7.58%88.19B | 23.74%52.01B | 10.36%25.84B | -16.27%188.24B | -36.88%81.98B | -53.48%42.03B |
Basic earnings per share | 64.80%15.346 | 74.81%9.59 | 64.37%4.479 | -38.32%12.186 | 8.34%9.312 | 24.48%5.486 | 11.00%2.725 | -16.27%19.757 | -36.96%8.595 | -53.57%4.407 |
Diluted earnings per share | 65.38%15.008 | 75.80%9.377 | 66.20%4.386 | -38.54%11.887 | 8.06%9.075 | 23.47%5.334 | 9.78%2.639 | -16.50%19.341 | -36.92%8.398 | -53.54%4.32 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.